Venus | Four Qiming Venture Partners Portfolio Companies Named "Zhuoyao Stars" in Third Annual CIC Awards
The list focuses on innovative enterprises with technological strength, innovation value, and growth resilience in areas such as artificial intelligence, digital intelligence innovation, and intelligent robotics.
Recently, CIC灼识咨询 released its Zhuyao Heat Ranking, with this year's list focusing on innovative enterprises with technological strength, innovative value, and growth resilience in artificial intelligence, digital intelligence innovation, intelligent robotics, and other fields.
Qiming Venture Partners portfolio companies DeepWise, Galaxy Universal, Mech-Mind Robotics, and 52TOYS were named third annual "Zhuyao Star" enterprises.
DeepWise (Artificial Intelligence) Galaxy Universal (Intelligent Robotics) Mech-Mind Robotics (Strategic Emerging Industries) 52TOYS (Refined Lifestyle) Named third annual "Zhuyao Star" enterprises
Zhuyao Heat Ranking
Drawing on project research experience and an expert think tank, the organizer selected this list across multiple dimensions including technological leadership, industry influence, investment and financing activity, and public attention, following multiple rounds of desk research and in-depth interviews.
This marks the third consecutive year that CIC灼识咨询 has published this ranking. The goal of the selection is to identify the most promising and noteworthy enterprises in this year's hottest sectors, helping them gradually grow into future industry leaders.
Amid global waves of transformation, these vibrant emerging enterprises will steadily advance and continuously break through with innovative thinking, advanced technology, and quality products and services, injecting new vitality and momentum into the economic development of China and the world.
Past Highlights
Qiming Venture Partners was founded in 2006. The firm currently manages 11 USD funds and 7 RMB funds, with total committed capital reaching $9.5 billion. Since its inception, Qiming Venture Partners has focused on investing in outstanding early and growth-stage companies in the Technology and Consumer (T&C) and Healthcare sectors.
To date, Qiming Venture Partners has invested in over 580 high-growth innovative enterprises, of which more than 210 have gone public on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through mergers and acquisitions. Over 80 companies have become recognized unicorns or super-unicorns.
Many of Qiming Venture Partners' portfolio companies have grown into the most influential companies in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), UBTECH (09880.HK), WeRide (NASDAQ:WRD), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), APT Medical (688617.SH), New Horizon Health (06606.HK), Sanyou Medical (688085.SH), AmoyDx (300685.SZ), Berry Genomics (000710.SZ), Sinocelltech (688520.SH), Yuanxin Technology, Caidya, Belief BioMed, Biren Technology, and others.